Accounts Payable / Remittance Processing

PRODUCTS

  • From product development to translation into clinical trials, GTx’s clinically validated scalable electroporation technology is equipped to handle your most complex cellular engineering demands.

    • Rapidly transfect from 75 thousand to 20 billion cells
    • Move forward with 21 CFR Part 11 enabled software
    • Develop quickly with an established regulatory path supported by a FDA Master File
    • Manufacture confidently with closed, cGMP-compliant, ISO-certified and CE-marked products
    • Enjoy MaxCyte’s proprietary Flow Electroporation® technology
  • The AMM-9862PSM is a compact, wideband gain block amplifier designed for high-performance RF applications.

  • This solvent-free process uses rapid frictional and thermal energy to create stable amorphous dispersions in seconds, enabling high drug loads, improved bioavailability, and easier scale-up.

     

  • Characterize Samples and Identify Unknown Components

    Do you often need to identify unknown compounds from complex samples? ACD/MS Structure ID Suite offers a simple, replicable workflow for generating and narrowing down structural candidates.

    • Deconvolute complex LC/MS and GC/MS data into individual component traces
    • Search proprietary and commercial databases for spectral matches
    • Search PubChem for accurate-mass and molecular-formula matches
    • Narrow down candidate structures by retention time and fragment include/exclude lists
  • The industry’s leading scalable electroporation technology for high-yield, transient expression of complex proteins, vaccines, and biologics.

    • Rapidly transfect from 75 thousand to 20 billion cells
    • High efficiency and cell viability enable flexible media strategies that can deliver significant cost savings
    • Improved yields from transient expression for decreased development timelines
    • Proprietary Flow Electroporation® Technology
    • Faster production of stable clones
    • ISO-certified and CE-marked

WHITE PAPERS AND CASE STUDIES

NEWS